Cargando…

Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B

Detalles Bibliográficos
Autor principal:	Choi, Jonggi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018298/ https://www.ncbi.nlm.nih.gov/pubmed/36918269 http://dx.doi.org/10.5009/gnl230070

Ejemplares similares

How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?
por: Loglio, Alessandro, et al.
Publicado: (2020)

Quantitative hepatitis B surface antigen predicts the antiviral response and hepatocellular carcinoma development in patients with chronic hepatitis B
por: Kim, Sung Eun
Publicado: (2017)

Correlation Between Quantitative Hepatitis B Surface Antigen and Hepatitis B Virus Deoxyribonucleic Acid Levels in Hepatitis B e Antigen-Positive and Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients
por: Nirmala, Viva Finhar Insani, et al.
Publicado: (2023)

Functional cure of chronic hepatitis B – predictable?
por: Gerlich, Wolfram
Publicado: (2021)

Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance
por: Taniguchi, Hideaki, et al.
Publicado: (2020)

Evaluation and Determination of Quantitative Hepatitis B Surface Antigen Diagnostic Performance in Chronic Hepatitis B Virus-Infected Patients
por: Islam, S M Rashed Ul, et al.
Publicado: (2023)

Hepatitis B Virus RNA Detection and a Mindful Use of Serum Hepatitis B Virus DNA and Hepatitis B Surface Antigen Measures in Clinical Practice
por: Brunetto, Maurizia R.
Publicado: (2020)

High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2012)

Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B
por: Li, Ming-Hui, et al.
Publicado: (2018)

Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
por: Yim, Sun Young, et al.
Publicado: (2017)

ELISA for Quantitative Determination of Hepatitis B Virus Surface Antigen
por: Kim, Se-Ho
Publicado: (2017)

Necessity for Hepatitis B Surface Antigen Screening in Pregnant Females in Iran
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B
por: Feitelson, Mark A., et al.
Publicado: (2022)

Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B
por: Kim, Tae Hyung, et al.
Publicado: (2018)

Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2012)

Are Serum Quantitative Hepatitis B Surface Antigen Levels, Liver Histopathology and Viral Loads Related in Chronic Hepatitis B-infected Patients?
por: Balkan, Ayhan, et al.
Publicado: (2016)

Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients
por: Tatar, Bengü, et al.
Publicado: (2020)

Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B
por: Choi, Hannah S.J., et al.
Publicado: (2021)

Seroconversion of Hepatitis B Virus Surface Antigen in Chronic Hepatitis B Child Treated with Entecavir
por: Li, Dong, et al.
Publicado: (2012)

Chronic Kidney Disease and Hepatitis B Virus Surface Antigenemia
por: Lee, Sung Woo, et al.
Publicado: (2018)

A “sandwich” strategy for functional cure of chronic hepatitis B
por: Wang, Xuan-Yi, et al.
Publicado: (2018)

Functional cure for chronic hepatitis B: accessibility, durability, and prognosis
por: Song, Aixin, et al.
Publicado: (2021)

Overlapping Gene Mutations of Hepatitis B Virus in a Chronic Hepatitis B Patient with Hepatitis B Surface Antigen Loss during Lamivudine Therapy
por: Lee, Sun-Young, et al.
Publicado: (2005)

Growing attention to an old marker, hepatitis B surface antigen, in the natural history of chronic hepatitis B
por: Jang, Jeong Won
Publicado: (2010)

Elecsys Hepatitis B Surface Antigen Quantitative Assay: Performance Evaluation and Correlation with Hepatitis B Virus DNA during 96 Weeks of Follow-up in Chronic Hepatitis B Patients
por: Lee, Hyun Ji, et al.
Publicado: (2012)

On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B
por: Gao, Yu-Hua, et al.
Publicado: (2016)

The clinical value of serum hepatic parenchyma cell volume-normalized hepatitis B surface antigen levels in hepatitis B e antigen -positive and -negative chronic hepatitis B patients
por: Tan, Lei, et al.
Publicado: (2021)

Role of quantitative hepatitis B surface antigen in predicting inactive carriers and HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients
por: Ungtrakul, Teerapat, et al.
Publicado: (2017)

Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
por: Li, Ming-Hui, et al.
Publicado: (2017)

Hepatitis B functional cure and immune response
por: Zheng, Jia-Rui, et al.
Publicado: (2022)

Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study
por: Sonneveld, Milan J, et al.
Publicado: (2020)

A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection
por: Zeng, Da-Wu, et al.
Publicado: (2016)

Genetic variation of hepatitis B surface antigen among acute and chronic hepatitis B virus infections in The Netherlands
por: Cremer, Jeroen, et al.
Publicado: (2018)

Early hepatitis B surface antigen decline predicts treatment response to entecavir in patients with chronic hepatitis B
por: Peng, Cheng-Yuan, et al.
Publicado: (2017)

Hepatitis B Surface Antigen (HBsAg) Kinetics in Chronic Hepatitis B Patients during Peginterferon Treatment
por: Wang, Kaifa, et al.
Publicado: (2020)

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
por: Lok, Anna S., et al.
Publicado: (2019)

Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection
por: Wu, Shuling, et al.
Publicado: (2022)

Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis
por: Zhang, Zhan-qing, et al.
Publicado: (2019)

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
por: Lee, Sung Won, et al.
Publicado: (2021)

Usefulness of a Hepatitis B Surface Antigen-Based Model for the Prediction of Functional Cure in Patients with Chronic Hepatitis B Virus Infection Treated with Nucleos(t)ide Analogues: A Real-World Study
por: Caviglia, Gian Paolo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cke7cbd5c0i8803l5hrgkrf6no